Prime editing, introduced by David Liu’s group at the Broad Institute in 2019, combined a catalytically impaired Cas9 nickase with an engineered reverse transcriptase and a guide RNA that carries both the targeting information and the template for the desired edit. The system writes new sequence directly into the genome without making a full double-strand break, avoiding the chaotic repair outcomes that plague conventional CRISPR-Cas9 cutting. Yet prime editing has always faced a ceiling: the efficiency and precision of the approach decline sharply as the requested edit grows larger. Insertions of more than a few dozen base pairs become unreliable, and integrating entire genes or rearranging chromosome segments has remained largely out of reach.

Prime assembly tackles that ceiling by reconceiving the edit as a stepwise construction process rather than a single copying event. Instead of forcing the reverse transcriptase to polymerize a long, unwieldy DNA tract in one continuous reaction, the system orchestrates a series of coordinated sub-edits, each installing a defined fragment at the target locus. Because each fragment is short enough to be written with high fidelity, the assembled product can extend to kilobase scale while maintaining the sequence accuracy that defines prime editing. The design encodes overlapping junctions within the delivered template RNAs so that successive fragments anneal to one another and to the genomic target, stitching the pieces into a contiguous, correctly ordered insert.

The molecular choreography relies on a redesigned editing complex. The researchers report engineering the prime editor apparatus and its guide RNA architecture so that multiple template modules can be loaded and processed in a defined sequence at the same target site. Timing and polarity matter enormously in genome writing: a fragment installed out of order, or in the wrong orientation, would leave behind scars or truncate the intended product. The prime assembly system addresses this by controlling the order in which template segments are reverse-transcribed and by using nicking patterns that favor progressive extension of the nascent strand. In effect, the genome itself becomes the scaffold on which the new sequence is assembled, and the cell’s own repair machinery seals the final junctions.

What distinguishes the work most sharply from earlier large-insert methods is the degree of control over rearrangement. Transposon-based delivery systems can move large cargoes but do so at their own preferred genomic sites, and double-strand-break-dependent methods such as CRISPR paired with homologous recombination or non-homologous end joining frequently generate a messy mixture of deletions, inversions, and random integrations. Prime assembly, by contrast, specifies both the landing site and the structure of the rearrangement. The paper demonstrates targeted integration of sizable genetic payloads, precise excision of unwanted segments, and programmable reorganization of DNA segments within a locus, all without introducing a double-strand break at any point in the procedure.

The technical benchmarks reported in the study emphasize both efficiency and purity. Across the demonstrated edit classes, the authors describe insertion products that are predominantly exact, with detectable byproducts reduced relative to break-dependent alternatives. Sequence-level analysis of the assembled products shows the expected junction architecture, an important indicator that the overlapping-fragment design behaves as intended rather than relying on stochastic recombination. Editing outcomes were profiled at the DNA level with deep sequencing and, for the larger rearrangements, with long-read sequencing capable of confirming the structure of multi-kilobase changes end to end, a level of verification that smaller-scale editing studies rarely require.

The implications for disease research are considerable. A large fraction of pathogenic mutations are not simple point substitutions. Thousands of known genetic disorders arise from deletions, duplications, insertions of mobile elements, or larger structural changes that conventional single-nucleotide editors cannot address. Gene-addition therapies using viral vectors can deliver a working copy of a gene, but they insert it at a semi-random safe-harbor location rather than restoring the native locus, losing native regulation and occasionally provoking insertional complications. Prime assembly offers a route to writing a functional gene back into its endogenous position, complete with its own regulatory context, or to rebuilding a damaged locus from the bottom up.

Synthetic genome engineering stands to benefit even more directly. Building entire chromosomes and synthetic genomes has so far depended on laborious cycles of homologous recombination in yeast or on assembly in vitro followed by transplantation, approaches that are slow and species-limited. A method that can integrate large designed sequences at user-chosen genomic addresses in mammalian or other difficult cells would compress that workflow dramatically. The authors’ demonstration of programmable rearrangement suggests a longer-term vision in which genome architecture itself, not merely gene sequence, becomes an editable design parameter, allowing researchers to test in weeks what once took years of strain construction.

As with every genome-editing advance, the distance between a demonstration in cultured cells and a therapeutic reality is substantial. Delivery remains the field’s perennial bottleneck: prime editors are large multi-component systems, and a prime assembly platform that carries multi-part template cargoes is larger still, making efficient in vivo delivery a formidable engineering problem in its own right. Off-target activity, immunogenicity of the bacterial-derived editor proteins, and the long-term stability of large engineered loci will all need rigorous assessment. The authors and the field more broadly will also need to establish how the method performs in primary cells, tissues, and whole organisms, where chromatin context and cell-cycle state strongly influence repair outcomes.

Even with those caveats, prime assembly represents a conceptual milestone in the transition of genome editing from correction to construction. The first decade of CRISPR made cutting routine; the second made precise rewriting of individual letters increasingly reliable. Prime assembly points toward a third phase in which geneticists can move, add, and reorganize whole stretches of the genome with the same programmability that made base editing famous. For patients with structural variants that no current therapy can touch, and for engineers attempting to build genomes to specification, the ability to assemble DNA in place, fragment by fragment, at the exact location of choice, may prove to be one of the more consequential ideas to emerge from the genome-writing field in years.

Subject of Research: Prime assembly genome editing for targeted DNA integration and rearrangement

Article Title: Targeted genomic integration and rearrangement using prime assembly

Article References: Levesque, S., Kawashima, N., Hwang, G.-H., Zeng, J., Toskov, V., Barry, T., Mannherz, W., Homfeldt, L., Becerra, B., Schoonenberg, V. A. C., Pinello, L., Agarwal, S., & Bauer, D. E. (2026). Targeted genomic integration and rearrangement using prime assembly. Nature. https://doi.org/10.1038/s41586-026-11024-2

Image Credits: AI Generated

DOI: 10.1038/s41586-026-11024-2

Keywords: prime assembly, prime editing, genome editing, gene writing, CRISPR, reverse transcriptase, DNA integration, structural variants, synthetic genomics, gene therapy, molecular biology, biotechnology